Weng Tao

Person

People

Patents Grantslast 30 patents

Information Patent Grant
Use of encapsulated cell therapy for treatment of ophthalmic disorders
- Patent number 11,207,266
- Issue date Dec 28, 2021
- Neurotech, USA, Inc.
- Jeffrey Louis Goldberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of encapsulated cell therapy for treatment of ophthalmic disorders
- Patent number 10,456,356
- Issue date Oct 29, 2019
- Neurotech USA, Inc.
- Jeffrey Louis Goldberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of encapsulated cell therapy for treatment of ophthalmic disorders
- Patent number 10,195,140
- Issue date Feb 5, 2019
- Neurotech USA, Inc.
- Cahil McGovern
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cell lines that secrete anti-angiogenic antibody-scaffolds and solu...
- Patent number 10,004,804
- Issue date Jun 26, 2018
- Neurotech USA, Inc.
- Vincent Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Micronized device for the delivery of biologically active molecules...
- Patent number 9,265,814
- Issue date Feb 23, 2016
- Neurotech USA, Inc.
- Konrad Kauper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cell lines that secrete anti-angiogenic antibody-scaffolds and solu...
- Patent number 9,149,427
- Issue date Oct 6, 2015
- Neurotech USA, Inc.
- Vincent Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Micronized device for the delivery of biologically active molecules...
- Patent number 7,820,195
- Issue date Oct 26, 2010
- Neurotech USA, Inc.
- Konrad Kauper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cell surface molecule-induced macrophage activation
- Patent number 7,189,837
- Issue date Mar 13, 2007
- Neurotech S.A.
- Weng Tao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
ARPE-19 as a platform cell line for encapsulated cell-based delivery
- Patent number 7,115,257
- Issue date Oct 3, 2006
- Neurotech S.A.
- Weng Tao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Retinal cell lines with extended life-span and their applications
- Patent number 6,878,544
- Issue date Apr 12, 2005
- Neurotech S.A.
- John Greenwood
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cell surface molecule-induced macrophage activation
- Patent number 6,506,891
- Issue date Jan 14, 2003
- Neurotech S.A.
- Weng Tao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
ARPE-19 as a platform cell line for encapsulated cell-based delivery
- Patent number 6,361,771
- Issue date Mar 26, 2002
- Neurotech S.A.
- Weng Tao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1gG /transferrin receptor fusion protein
- Patent number 6,225,448
- Issue date May 1, 2001
- Neurotech S.A.
- Weng Tao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cell surface molecule-induced macrophage activation
- Patent number 6,197,294
- Issue date Mar 6, 2001
- Neurotech S.A.
- Weng Tao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS
- Publication number 20240285521
- Publication date Aug 29, 2024
- Neurotech USA, Inc.
- Jeffrey Louis GOLDBERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS
- Publication number 20220071897
- Publication date Mar 10, 2022
- Neurotech USA, Inc.
- Jeffrey Louis GOLDBERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS
- Publication number 20200197297
- Publication date Jun 25, 2020
- Neurotech USA, Inc.
- Jeffrey Louis GOLDBERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Encapsulated Cell Therapy for Treatment of Ophthalmic Disorders
- Publication number 20180055766
- Publication date Mar 1, 2018
- Neurotech USA, Inc.
- Cahil McGovern
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Use of Encapsulated Cell Therapy for Treatment of Ophthalmic Disorders
- Publication number 20160346197
- Publication date Dec 1, 2016
- Neurotech USA, Inc.
- Jeffrey Louis Goldberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF PEDF IN AN ENCAPSULATED CELL-BASED DELIVERY SYSTEM
- Publication number 20160120695
- Publication date May 5, 2016
- Neurotech USA, Inc.
- Weng Tao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CELL LINES THAT SECRETE ANTI-ANGIOGENIC ANTIBODY-SCAFFOLDS AND SOLU...
- Publication number 20150328312
- Publication date Nov 19, 2015
- Neurotech USA, Inc.
- Vincent Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cell Lines That Produce Prostaglandin F2 Alpha (PGF2A) And Uses The...
- Publication number 20150024024
- Publication date Jan 22, 2015
- NEUROTECH USA, INC.
- Weng Tao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cell Lines That Secrete Anti-Angiogenic Antibody-Scaffolds and Solu...
- Publication number 20120141573
- Publication date Jun 7, 2012
- Vincent Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Micronized Device for the Delivery of Biologically Active Molecules...
- Publication number 20110236457
- Publication date Sep 29, 2011
- Konrad Kauper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of PEDF in an Encapsulated Cell-Based Delivery System
- Publication number 20110111008
- Publication date May 12, 2011
- Weng Tao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CELL LINES THAT PRODUCE PROSTAGLANDIN F2 ALPHA (PGF2a) AND USES THE...
- Publication number 20100272780
- Publication date Oct 28, 2010
- Vincent Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based Delivery
- Publication number 20090269319
- Publication date Oct 29, 2009
- NEUROTECH USA, INC.
- Weng Tao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based Delivery
- Publication number 20090269389
- Publication date Oct 29, 2009
- NEUROTECH USA, INC.
- Weng Tao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Micronized device for the delivery of biologically active molecules...
- Publication number 20070154524
- Publication date Jul 5, 2007
- Konrad Kauper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARPE-19 as platform cell line for encapsulated cell-based delivery
- Publication number 20070071734
- Publication date Mar 29, 2007
- Weng Tao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cell surface molecule-induced macrophage activation
- Publication number 20030120059
- Publication date Jun 26, 2003
- Weng Tao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cell surface molecule-induced macrophage activation
- Publication number 20010046490
- Publication date Nov 29, 2001
- Weng Tao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Person

Patents Grantslast 30 patents

Use of encapsulated cell therapy for treatment of ophthalmic disorders

Use of encapsulated cell therapy for treatment of ophthalmic disorders

Use of encapsulated cell therapy for treatment of ophthalmic disorders

Cell lines that secrete anti-angiogenic antibody-scaffolds and solu...

Micronized device for the delivery of biologically active molecules...

Cell lines that secrete anti-angiogenic antibody-scaffolds and solu...

Micronized device for the delivery of biologically active molecules...

Cell surface molecule-induced macrophage activation

ARPE-19 as a platform cell line for encapsulated cell-based delivery

Retinal cell lines with extended life-span and their applications

Cell surface molecule-induced macrophage activation

ARPE-19 as a platform cell line for encapsulated cell-based delivery

1gG /transferrin receptor fusion protein

Cell surface molecule-induced macrophage activation

Patents Applicationslast 30 patents

USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS

USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS

USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS

Use of Encapsulated Cell Therapy for Treatment of Ophthalmic Disorders

Use of Encapsulated Cell Therapy for Treatment of Ophthalmic Disorders

USE OF PEDF IN AN ENCAPSULATED CELL-BASED DELIVERY SYSTEM

CELL LINES THAT SECRETE ANTI-ANGIOGENIC ANTIBODY-SCAFFOLDS AND SOLU...

Cell Lines That Produce Prostaglandin F2 Alpha (PGF2A) And Uses The...

Cell Lines That Secrete Anti-Angiogenic Antibody-Scaffolds and Solu...

Micronized Device for the Delivery of Biologically Active Molecules...

Use of PEDF in an Encapsulated Cell-Based Delivery System

CELL LINES THAT PRODUCE PROSTAGLANDIN F2 ALPHA (PGF2a) AND USES THE...

ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based Delivery

ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based Delivery

Micronized device for the delivery of biologically active molecules...

ARPE-19 as platform cell line for encapsulated cell-based delivery

Cell surface molecule-induced macrophage activation

Cell surface molecule-induced macrophage activation